Development of Chemoproteomic Platforms For Protein-Ligand Interaction Discovery and Affinity Measurement
Charles David Warren Tri-Institutional PhD Program in Chemical Biology (TPCB) Chairperson: Dr. Daniel Bachovchin Major Sponsor: Dr. Jacob Geri Minor Sponsors: Dr. Samie Jaffrey and Dr. Ekaterina…
Read the full articleYou might also wanna read
Global protein-ligand binding affinity profiling via photocatalytic labeling
New approach integrates protein-ligand binding affinity profiling and photocatalytic labeling into a single step, enhancing drug discovery w
Physics-based generative approach enables de novo design of ligand-binding proteins and biosensors
The de novo design of ligand-binding proteins has tremendous potential to revolutionize biosensor technology, yet converting these designs i
biorxiv.org·1d agoUnified Network for Integrated Fluid Collection at Yale
Conditions : Molecular Residual Disease; Cancer Sponsors : Yale University Not yet recruiting
The future of computational biology for macromolecules in the age of AI: challenges and opportunities
We have seen more progress in computational biology for macromolecules in the last five years than we experienced in the five preceding deca
journals.plos.org·7d agoThe future of computational biology for macromolecules in the age of AI: challenges and opportunities
We have seen more progress in computational biology for macromolecules in the last five years than we experienced in the five preceding deca
journals.plos.org·7d ago
Postdoctoral Research Fellow Position in Covalent Chemical Biology at Dana-Farber Cancer Institute
Postdoctoral Research Fellow - Lyn Jones Lab job
careers.dana-farber.org·1mo ago
Outstanding Scientific Achievement Award lecturer highlights evolution of unimolecular therapies
Timo D. Müller, PhD, shared his insights on hormonal control of metabolism by glucose-dependent insulinotropic polypeptide (GIP) and next-ge
Comments
Sign in to join the conversation.
No comments yet. Be the first.